Terms: = Leukemia AND KIF5B, ENSG00000170759, 3799, P33176, UKHC, KNS1, KNS, KINH
8 results:
1. Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers.
Roskoski R; Sadeghi-Nejad A
Pharmacol Res; 2018 Feb; 128():1-17. PubMed ID: 29284153
[TBL] [Abstract] [Full Text] [Related]
2. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.
Menezes J; Acquadro F; Wiseman M; Gómez-López G; Salgado RN; Talavera-Casañas JG; Buño I; Cervera JV; Montes-Moreno S; Hernández-Rivas JM; Ayala R; Calasanz MJ; Larrayoz MJ; Brichs LF; Gonzalez-Vicent M; Pisano DG; Piris MA; Álvarez S; Cigudosa JC
Leukemia; 2014 Apr; 28(4):823-9. PubMed ID: 24072100
[TBL] [Abstract] [Full Text] [Related]
3. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
[TBL] [Abstract] [Full Text] [Related]
4. Identification of a high-affinity network of secretagogin-binding proteins involved in vesicle secretion.
Bauer MC; O'Connell DJ; Maj M; Wagner L; Cahill DJ; Linse S
Mol Biosyst; 2011 Jul; 7(7):2196-204. PubMed ID: 21528130
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms of cytotoxicity of 2- or 2,6-di-tert-butylphenols and 2-methoxyphenols in terms of inhibition rate constant and a theoretical parameter.
Kadoma Y; Ito S; Atsumi T; Fujisawa S
Chemosphere; 2009 Feb; 74(5):626-32. PubMed ID: 19084262
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a novel imatinib responsive kif5b-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia.
Score J; Curtis C; Waghorn K; Stalder M; Jotterand M; Grand FH; Cross NC
Leukemia; 2006 May; 20(5):827-32. PubMed ID: 16498388
[TBL] [Abstract] [Full Text] [Related]
7. [Nationwide survey of allogeneic peripheral blood stem cell transplantation from related donors in Japan: current trends and issues].
Harada M; Takenaka K; Nakao S; Aotsuka N; Sawada H; Shinagawa K; Kasai M; Iseki T; Murata M; Okamoto S; Hyodo H; Kodera Y
Rinsho Ketsueki; 1999 Nov; 40(11):1160-7. PubMed ID: 10624126
[TBL] [Abstract] [Full Text] [Related]
8. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
[TBL] [Abstract] [Full Text] [Related]
